INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | -55.6% | 2,284 | -9.0% | 0.00% | -40.0% |
| Q1 2022 | $9,000 | -59.1% | 2,510 | -18.6% | 0.01% | -61.5% |
| Q3 2021 | $22,000 | -24.1% | 3,085 | -0.1% | 0.01% | -23.5% |
| Q2 2021 | $29,000 | -3.3% | 3,087 | -5.4% | 0.02% | +30.8% |
| Q1 2021 | $30,000 | +3.4% | 3,264 | +0.0% | 0.01% | -35.0% |
| Q4 2020 | $29,000 | -65.5% | 3,263 | +5.2% | 0.02% | -73.7% |
| Q2 2020 | $84,000 | +425.0% | 3,102 | +44.6% | 0.08% | +322.2% |
| Q1 2020 | $16,000 | +128.6% | 2,145 | +5.9% | 0.02% | +200.0% |
| Q4 2019 | $7,000 | +75.0% | 2,025 | -1.1% | 0.01% | +50.0% |
| Q3 2019 | $4,000 | -33.3% | 2,048 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $6,000 | – | 2,048 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Triatomic Management LP | 235,000 | $405,000 | 0.23% |
| Green Alpha Advisors, LLC | 147,380 | $254,000 | 0.22% |
| Financial Advocates Investment Management | 14,161 | $628,000 | 0.05% |
| Virtus ETF Advisers LLC | 72,540 | $125,000 | 0.05% |
| Cedar Brook Financial Partners, LLC | 88,750 | $153,094 | 0.05% |
| Rafferty Asset Management, LLC | 2,363,189 | $4,077,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 352,721 | $608,000 | 0.04% |
| CAXTON ASSOCIATES LP | 130,728 | $226,000 | 0.03% |
| Keystone Financial Group | 74,058 | $128,000 | 0.03% |
| Virtu Financial LLC | 130,829 | $226,000 | 0.02% |